Highly Recommended:

Letters To President Obama        

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
             MARIJUANA PROHIBITION
      video:  Why is The Only Cancer Cure in the World illegal?

THEY KNOW:




THEY KNOW:

US National Library of Medicine National Institutes of Health                                                   
 Cannabinoids inhibit cellular respiration of human oral cancer cells

WHY IS MARIJUANA LISTED BY THE DEA AS HAVING NO MEDICAL VALUE?


US Department Of Justice
Drug Enforcement Administration
Office of Diversion Control

Definition of Controlled Substance Schedules

The drugs and other substances that are considered controlled substances under the CSA are divided into five schedules. A listing of the substances and their schedules is found in the DEA regulations, 21 C.F.R. Sections 1308.11 through 1308.15. A controlled substance is placed in its respective schedule based on whether it has a currently accepted medical use in treatment in the United States and its relative abuse potential and likelihood of causing dependence. Some examples of controlled substances in each schedule are outlined below.

NOTE: Drugs listed in schedule I have no currently accepted medical use in treatment in the United States and, therefore, may not be prescribed, administered, or dispensed for medical use. In contrast, drugs listed in schedules II-V have some accepted medical use and may be prescribed, administered, or dispensed for medical use.

Schedule I Controlled Substances

Substances in this schedule have a high potential for abuse, have no currently accepted medical use in treatment in the United States, and there is a lack of accepted safety for use of the drug or other substance under medical supervision.

Some examples of substances listed in schedule I are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), peyote, methaqualone, and 3,4-methylenedioxymethamphetamine (“ecstasy”).

Donald Abrams, M.D. is chief of Hematology and Oncology at San Francisco General Hospital and the co-author—with Andrew Weil—of Integrative Oncology (Oxford University Press). Abrams has extensive experience working with cancer and HIV/AIDS patients and is a pioneer in the field of medical cannabis research.

Marijuana Must Be Legalized

please read:  http://t.co/1ykXwmGj